Litcius/Paper detail

Antipsychotic effect of diosgenin in ketamine-induced murine model of schizophrenia: Involvement of oxidative stress and cholinergic transmission

Benneth Ben‐Azu, Olusegun G. Adebayo, Aliance Romain Fokoua, Benjamin Oritsemuelebi, Emmanuel O. Chidebe, Chukwuebuka B. Nwogueze, Lenatababari Kumanwee, God'swill E. Uyere, Micheal T. Emuakpeje

2024IBRO Neuroscience Reports34 citationsDOIOpen Access PDF

Abstract

./day) treatment from days 8-14. Mice were assessed for behavioral changes. Oxidative, nitrergic markers, and cholinergic (acetylcholinesterase activity) transmission were examined in the striatum, prefrontal-cortex and hippocampus. Diosgenin prevented and reversed hyperlocomotion, cognitive and social deficits in mice treated with ketamine relative to ketamine groups. The increased acetylcholinesterase, malondialdehyde and nitrite levels produced by ketamine were reduced by diosgenin in the striatum, prefrontal-cortex and hippocampus, but did not reverse striatal nitrite level. Diosgenin increased glutathione, and catalase levels, except for hippocampal catalase activity when compared with ketamine controls. Conclusively, these biochemical changes might be related to the behavioral deficits in ketamine-treated mice, which were prevented and reversed by diosgenin.

Topics & Concepts

KetamineDiosgeninOxidative stressPharmacologyChemistryCholinergicEndocrinologyInternal medicineMedicineAnesthesiaOrganic chemistryTryptophan and brain disordersNeuroscience and Neuropharmacology ResearchStress Responses and Cortisol